AJK Biopharmaceutical

AJK Biopharmaceutical is a US-based biotechnology company specializing in the clinical development of novel anti-infective drugs. Based in Irvine, California, we are dedicated to combating life-threatening infectious diseases by developing broad-spectrum antimicrobial cyclic peptides, including anti-fungal and antiviral peptides.

Our focus is on creating innovative solutions to address the growing challenge of multi-drug resistant bacteria. We leverage expertise in microbiology and chemistry, alongside medicinal chemistry, to discover and develop effective antimicrobial agents.

AJK Biopharmaceutical’s mission is to provide healthcare practitioners with critical new approaches to infection disease therapy, and we are committed to analytical chemistry and biochemistry, as well as corporate development and strategic planning. Founded in 2018, we currently employ a team of 3-50 professionals.